// App-Quantinova.ai

P3-06-50 : Thyroid function is associated with the response to neoadjuvant chemotherapy in breast cancer patients: Results from the NEOZOTAC trial on behalf of the Dutch Breast Cancer Research Group (BOOG 2010-01)

Researchers

Presenter

  • de Groot S

Principal Investigators

  • Charehbili A

  • Janssen LGM

  • van de Velde CJH

  • Nortier JWR

  • van der Hoeven JJM

  • Pijl H

  • Kessels LW

  • van Bochove A

  • van Laarhoven HWM

  • Meershoek-Klein Kranenbarg E

  • van Leeuwen-Stok AE

  • Liefers GJ

  • Kroep JR

  • Dijkgraaf EM

  • Smit VT

Medical Centers

  • Deventer Hospital, Deventer, Netherlands

  • Leiden University Medical Center, Leiden, NetherlandsAcademic Medical Center, Amsterdam, Noord-Holland, NetherlandsZaans Medical Center, Zaandam, Netherlands

  • Dutch Breast Cancer Research Group (BOOG), Amsterdam, Noord-Holland, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A